
201 - 500 employés
Fondée en 1998
🏥 Santé
💼 Conseil
📦 Logistique
💰 €4 137 483 Post-IPO Equity - Zealand Pharma en 2025-06
Healthcare • Consulting • Logistics
Zealand Pharma est une entreprise de biotechnologie internationale dont le siège est en Danemark avec des opérations à Boston, aux États-Unis. Elle découvre, conçoit et développe des thérapies à base de peptides et de petites molécules focalisées sur la transformation de la santé métabolique — notamment l'obésité — et sur des maladies rares telles que l'hyperinsulinisme congénital et le syndrome de l'intestin court, ainsi que sur des affections inflammatoires chroniques. Zealand entretient un pipeline clinique de peptides analogues et d'agonistes de récepteurs (par exemple, analogues de l'amylin, agonistes GLP/GIP, analogues du glucagon) et collabore avec de grandes entreprises pharmaceutiques pour faire avancer les programmes.
🕒 il y a 2 mois
🏖️ New Jersey, Pennsylvania – Distant
💵 $210 000 - $250 000 / an
⏰ Temps Plein
🔴 Expert
👔 Directeur
👻 Score fantôme 14%
🗣️🇺🇸🇬🇧 Anglais requis
Améliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.

201 - 500 employés
Fondée en 1998
🏥 Santé
💼 Conseil
📦 Logistique
💰 €4 137 483 Post-IPO Equity - Zealand Pharma en 2025-06
Healthcare • Consulting • Logistics
Zealand Pharma est une entreprise de biotechnologie internationale dont le siège est en Danemark avec des opérations à Boston, aux États-Unis. Elle découvre, conçoit et développe des thérapies à base de peptides et de petites molécules focalisées sur la transformation de la santé métabolique — notamment l'obésité — et sur des maladies rares telles que l'hyperinsulinisme congénital et le syndrome de l'intestin court, ainsi que sur des affections inflammatoires chroniques. Zealand entretient un pipeline clinique de peptides analogues et d'agonistes de récepteurs (par exemple, analogues de l'amylin, agonistes GLP/GIP, analogues du glucagon) et collabore avec de grandes entreprises pharmaceutiques pour faire avancer les programmes.
• Lead the design, execution, and communication of health, economic and outcomes research strategies supporting the company’s global metabolic health portfolio. • Generate high-quality real-world, clinical, and economic evidence to demonstrate product value to payers, providers, patients, and policymakers. • Develop and implement integrated global HEOR strategies to support pipeline and lifecycle management programs with a US launch focus. • Lead development of US RWD strategies and partnerships with academic consortia, claims databases, and health systems to support value demonstration effective effectiveness and longitudinal outcomes studies. • Design and implement real-world data analyses to understand and articulate the current patient demographics, treatment patterns, and outcomes. • Develop AMCP value dossiers, economic modelling and narratives and scientific publications to support value propositions. • Serve as a key domain expert for payer engagement, providing evidence summaries and presentations that strengthen product positioning and formulary access. • Engage and collaborate with external partners including payers, providers, and other access decision-makers to establish / maintain strong partnerships and gather insights. • Lead the external dissemination of HEOR/RWE deliverables including publications, presentations, and professional conferences. • Provide input to clinical development programs.
• PhD, PharmD, MPH, or Master’s in Health Economics, Outcomes Research, Epidemiology, or a related discipline. • 8–12 years of HEOR/RWE experience in biotech, pharmaceutical organizations or consultancies with demonstrated success in pre-launch and commercialization phases. • Therapeutic area expertise in metabolic, endocrine, or cardiometabolic diseases strongly preferred. • Deep understanding of payer and evidence requirements in the U.S. • Proficiency in RWD study design and analysis, and patient outcome measure development. • Proven ability to communicate complex data to non-technical audiences, including payers, regulators, and cross-functional business leaders. • Experience leading external collaborators, vendors, and cross-company joint HEOR initiatives. • Publication track record and presentation experience at peer-reviewed scientific meetings.
• Excellent teamwork • Strong engagement across the organization
Postuler Maintenant🕒 il y a 2 mois
Director of Transaction Advisory Services at KSM, managing due diligence projects for private equity and corporate clients. Leading teams and developing client relationships in a dynamic environment.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 2 mois
Project Director leading high-value customer automation programs at FORTNA. Overseeing execution for projects exceeding $60M with significant travel requirements.
🇺🇸 États-Unis – Télétravail
💰 Private Equity Round en 2019-03
⏰ Temps Plein
🔴 Expert
👔 Directeur
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 2 mois
Seeking a Strategic Alliance Director at Digital Hands for cybersecurity services. Role emphasizes on driving new business and managing relationships with enterprise clients.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 2 mois
Strategic Accounts Director at GCG focusing on data center infrastructure revenue growth. Building relationships with key accounts and driving adoption of power distribution and connectivity solutions.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 2 mois
Clinical Development Director leading early phase clinical development for cardiometabolic/general medicine compounds at Amgen. Collaborating with teams to design and deliver innovative clinical trials.
🇺🇸 États-Unis – Télétravail
💵 $274 788 - $371 773 / an
💰 €28 500 000 000 Post-IPO Debt en 2022-12
⏰ Temps Plein
🔴 Expert
👔 Directeur
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis